Device Reproductive Health

Continuous Single Culturenx (Cscmnx)

Payments companies reported to CMS as associated with Continuous Single Culturenx (Cscmnx). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,792associated payments (2023-2025)
36clinicians with associated payments
1company reporting

By year

2025 $1,792

Payments reported as associated with Continuous Single Culturenx (Cscmnx), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Reproductive Endocrinology $1,138
Anatomic Pathology & Clinical Pathology $295
Obstetrics & Gynecology $285
Family Medicine $28.27
Gynecology $20.12

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Continuous Single Culturenx (Cscmnx)

These are the largest totals companies reported as associated with Continuous Single Culturenx (Cscmnx). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jaime Shamonki Santa Monica, CA Anatomic Pathology & Clinical Pathology $295.33
Mark Amols Mesa, AZ Reproductive Endocrinology $158.96
Kaylen Silverberg Austin, TX Reproductive Endocrinology $132.42
Paul Magarelli Denver, CO Reproductive Endocrinology $102.17
Pietro Bortoletto Boston, MA Reproductive Endocrinology $69.07
Armando Arroyo Worcester, MA Reproductive Endocrinology $67.02
Molina Dayal St. Louis, MO Reproductive Endocrinology $56.19
Violet Klenov Creve Coeur, MO Reproductive Endocrinology $56.19
Mira Aubuchon Chesterfield, MO Obstetrics & Gynecology $55.08
Peter Ahlering Saint Louis, MO Reproductive Endocrinology $55.08

Prescribed Continuous Single Culturenx (Cscmnx)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.